Champions Biotechnology Partners to Establish Agreements for Preclinical Evaluation of Oncology Drugs 12/18/08

Champions Biotechnology Reports Fiscal 2009 Second Quarter Financial Results 12/16/08

Of Mice and Men: Award-Winning Oncologist Leads New Advancement in Personalized Medicine

Champions Biotechnology, Inc. Reports Fiscal 2009 First Quarter Financial Results 9/16/2008

Champions Biotechnology, Inc. Retains The Investor Relations Group 8/14/2008

Champions Biotechnology, Inc. Earnings Release 7/30/2008

Champions Biotechnology, Inc. Begins Preclinical Development of Its Lead Oncology Drug Candidate 6/17/2008

Champions Biotechnology, Inc. and ImClone Systems Establish Agreement for Preclinical Evaluation of Oncology Drugs 5/07/2008

Champions Biotechnology, Inc. and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs 5/06/2008

Champions Biotechnology, Inc. Completes $2,500,000 Private Financing at $1.75 per Share 4/23/2008

Champions Biotechnology, Inc. Appoints New Board Members and Forms Management Team 4/01/2008

Champions Biotechnology, Inc. Reports Two Cents per Share Earnings 3/06/2008

Dr. David Sidransky Appointed Chairman of Champions Biotechnology, Inc. 10/23/2007

Dr. David Sidransky Appointed Director of Champions Biotechnology, Inc. 8/14/2007

Dr. Manuel Hidalgo Appointed Director and Scientific Advisor of Champions Biotechnology, Inc. 6/11/2007

Champions Biotechnology, Inc. acquires Biomerk, Inc.  05/21/2007

Champions Biotechnology, Inc. acquires rights to cancer drug candidates.  02/14/2007

Champions Sports, Inc. changes name to Champions Biotechnology, Inc.  01/22/2007